Sequoia Financial Advisors LLC Purchases 3,048 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sequoia Financial Advisors LLC grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 35.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,556 shares of the medical instruments supplier’s stock after purchasing an additional 3,048 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in DENTSPLY SIRONA were worth $219,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Pacer Advisors Inc. increased its stake in shares of DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock valued at $85,478,000 after acquiring an additional 4,473,972 shares in the last quarter. Cooke & Bieler LP increased its stake in shares of DENTSPLY SIRONA by 24.3% in the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock valued at $174,101,000 after acquiring an additional 1,794,391 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock valued at $49,990,000 after acquiring an additional 1,244,326 shares in the last quarter. Invenomic Capital Management LP bought a new stake in shares of DENTSPLY SIRONA in the 3rd quarter valued at $23,724,000. Finally, National Bank of Canada FI increased its stake in shares of DENTSPLY SIRONA by 85.8% in the 3rd quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier’s stock valued at $44,059,000 after acquiring an additional 751,800 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Morgan Stanley reduced their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research report on Tuesday, December 17th. Mizuho reduced their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, March 13th. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday, February 28th. Evercore ISI reissued an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Finally, Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and reduced their price target for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Twelve research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $23.33.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction dated Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Trading Down 0.4 %

NASDAQ XRAY opened at $15.60 on Friday. The stock has a market capitalization of $3.10 billion, a price-to-earnings ratio of -7.54, a PEG ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a one year low of $14.78 and a one year high of $33.72. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The business’s fifty day moving average is $17.97 and its 200-day moving average is $20.60.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.10%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s payout ratio is -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.